Malignant Melanoma Clinical Trials

A listing of Malignant Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Birmingham Alabama

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Arizona

UPDATED

Gilbert Arizona 85234

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Research Center
Los Angeles California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Research Center
Los Angeles California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Sacramento California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
San Diego California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
San Francisco California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

View More ▼

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Los Angeles California 90024

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Orange California 92868

A clinical trial seeking patients for a research study for the treatment of Melanoma or Malignant Melanoma

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

San Francisco California 94115

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Stanford California 94305

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Colorado

Research Center
Aurora Colorado

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Research Center
Aurora Colorado

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Denver Colorado

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

View More ▼

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

Aurora Colorado 80045

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of CMP-001 and Pembrolizumab to evaluate Stage IV Skin Melanoma

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Connecticut

Research Center
Farmington Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
New Haven Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

District of Columbia

Washington District of Columbia 20057

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Florida

Research Center
Miami Florida

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Miami Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Port St. Lucie Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Sarasota Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Tampa Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

View More ▼

UPDATED

Gainesville Florida 32608

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Sarasota Florida 34232

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

West Palm Beach Florida 33401

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Georgia

Research Center
Atlanta Georgia

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Illinois

Research Center
Chicago Illinois

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Chicago Illinois 60612

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Indiana

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of CMP-001 and Pembrolizumab to evaluate Stage IV Skin Melanoma

Kansas

Research Center
Fairway Kansas

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Research Center
Topeka Kansas

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Kentucky

Research Center
Louisville Kentucky

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

View More ▼

UPDATED

Lexington Kentucky 40536

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Maryland

Research Center
Baltimore Maryland

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Bethesda Maryland

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)